Facebook-f X-twitter Linkedin-in Instagram Youtube
  • BioTech, Finance, General, Industry, Investing, Pharmaceutical

UK-US Zero Tariff Deal on Pharmaceuticals

  • BioTech, Industry, Investing, North America, Pharmaceutical

Global Drugmakers Rush for U.S. Presence

  • BioTech, Finance, General, Industry, Investing, North America, Pharmaceutical

Pharma Stocks Split as Trump Unveils 100% Drug Tariff

become a subscriber and receive our newsletter

More Pharmaceutical

  • BioTech, Finance, Industry, Investing, North America, Pharmaceutical

Buy, Sell, or Hold: Hims & Hers Stock Surges 64%

  • BioTech, General, Investing, North America, Pharmaceutical

This Biotech’s Phase 3 Results Could Be a Game-Changer for Inves...

Early-Stage Biotech Gets $1.3B Boost From New Investor

‘Unusually Cautious’: Biotech Dealmakers Hit the Brakes

GSK Q1 Strength Signals Tariff Resilience

Trade War Hits Pharma: U.S.-EU Dispute Threatens Drug Prices

Novartis Bets Big on Cardiovascular Biotech With $3bn Anthos Deal

Swiss pharmaceutical giant Novartis has announced an agreement to acquire Anthos Therapeutics from Blackstone Life Sciences in a deal valued at up to $3.1 Billion. The deal includes a $925...

  • Pharmaceutical

New project announced to develop smart drugs for aggressive cancer...

  • BioTech, Pharmaceutical, Technologie

Cancer treatment could identify patients most likely t...

de_DEGerman
en_USEnglish de_DEGerman